Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 1:256:117900.
doi: 10.1016/j.lfs.2020.117900. Epub 2020 Jun 2.

The immune system and COVID-19: Friend or foe?

Fereshteh Yazdanpanah  1 , Michael R Hamblin  2 , Nima Rezaei  3
Affiliations
Review

The immune system and COVID-19: Friend or foe?

Fereshteh Yazdanpanah et al. Life Sci. .

Abstract

Aim: Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection caused by SARS-CoV-2, which has been became a global public health challenge. The pathogenesis of this virus is not yet clearly understood, but there is evidence of a hyper-inflammatory immune response in critically ill patients, which leads to acute respiratory distress syndrome (ARDS) and multi-organ failure.

Material and methods: A literature review was performed to identify relevant articles on COVID-19 published up to April 30, 2020. The search resulted in 361 total articles. After reviewing the titles and abstracts for inclusion, some irrelevant papers were excluded. Additional relevant articles were identified from a review of citations referenced.

Key findings: SARS-CoV-2, directly and indirectly, affects the immune system and avoids being eliminated in early stages. On the other hand, the secretion of inflammatory cytokines creates critical conditions that lead to multi-organ failure.

Significance: The immune system which is affected by the virus tries to respond via a cytokine storm and hyperinflammation, which itself leads to further multi-organ damage and even death.

Keywords: Acute respiratory distress syndrome; COVID-19; Cytokine storm; Hyperinflammation; Immune system.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no conflicts of interest.

Figures

Unlabelled Image
Graphical abstract
See this image and copyright information in PMC

References

    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. - PMC - PubMed
    1. Hanaei S., Rezaei N. COVID-19: Developing from an Outbreak to A Pandemic. Arch. Med. Res. 2020 doi: 10.1016/j.arcmed.2020.04.021. published online ahead of print, 2020 May 13. - DOI - PMC - PubMed
    1. Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J. Eur. Acad. Dermatol. Venereol. 2020 doi: 10.1111/jdv.16387. - DOI - PubMed
    1. Giamarellos-Bourboulis E.J., Netea M.G., Rovina N., Akinosoglou K., Antoniadou A., Antonakos N., Damoraki G., Gkavogianni T., Adami M.-E., Katsaounou P., Ntaganou M., Kyriakopoulou M., Dimopoulos G., Koutsodimitropoulos I., Velissaris D., Koufargyris P., Karageorgos A., Katrini K., Lekakis V., Lupse M., Kotsaki A., Renieris G., Theodoulou D., Panou V., Koukaki E., Koulouris N., Gogos C., Koutsoukou A. Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure. Cell Host Microbe. 2020 doi: 10.1016/j.chom.2020.04.009. - DOI - PMC - PubMed
    1. Di Gennaro F., Pizzol D., Marotta C., Antunes M., Racalbuto V., Veronese N. Coronavirus diseases (COVID-19) current status and future perspectives: a narrative review. Int. J. Environ. Res. Public Health. 2020;17(8) - PMC - PubMed

MeSH terms